Fig. 5From: Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapyRelationship between a exposure and tumor shrinkage rate, and b exposure and tumor progression rate. Cminss = steady-state trough concentration; MEL = melanoma; NSCLC = non-small cell lung cancer; RCC = renal cell carcinomaBack to article page